If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStreaksai Regulatory News (STK)

  • There is currently no data for STK

Director Resignation

4 Mar 2024 17:09

RNS Number : 5298F
StreaksAI PLC
04 March 2024
 

4 March 2024

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

StreaksAI PLC

 

("StreaksAI" or "the Company")

 

Director Resignation

 

StreaksAI PLC (LSE: STK), a UK-based generative AI platform, announces that Phil Blows has resigned as Chief Executive Officer and as a Director of the Company with immediate effect.

 

The Board would like to take this opportunity to thank Phil Blows for his contribution to the Company and wish him well for the future.

 

The Board also announces that Mike Edwards, Non-Executive Chairman of the Company, will assume the role of Interim CEO.

 

The Directors of StreaksAI take responsibility for this announcement.

 

For further information please contact:

StreaksAI PLC

 

Mike Edwards

Interim CEO

 

via First Sentinel (Corporate Advisor)

+44 20 3855 5551 

Corporate Brokers

 

Peter Krens (Tennyson Securities)

Brian Stockbridge (First Sentinel)

 

+44 207 186 9030

+44 20 3855 5551

 

About Streaks:

StreaksAI PLC is a provider of AI based conversational technologies. The Company offers two core products in the gaming and conversational AI space.

 

For more information on the Conversational Gaming AI product, please visit www.playstreaks.com.

 

For more information on the Conversational AI product, please visit www.streaks.ai.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZLFBZXLBBBE
12
Date   Source Headline
13th May 20253:26 pmRNSChange of Company Name and Strategic Update
29th Jan 20257:00 amRNSExercise of Warrants, PDMR and Grant of Warrants
24th Jan 202510:01 amRNSOperations Update
16th Jan 20259:23 amRNSLeadership Changes and Board Appointments
15th Jan 202512:20 pmRNSNotification of Investment
26th Nov 20249:43 amRNSTR-1 Notification
22nd Nov 20247:00 amRNSIssue of Warrants and PDMR
21st Nov 20247:00 amRNSIssue of Equity and PDMR
18th Nov 20247:00 amRNSInterim results
2nd Aug 202411:16 amRNSDirector Resignation
25th Jul 20245:57 pmRNSResults of Annual General Meeting
4th Jul 20244:28 pmRNSNotice of Annual General Meeting
28th Jun 20247:00 amRNSAnnual results
11th Mar 202410:31 amRNSDirector's Dealings
4th Mar 20245:09 pmRNSDirector Resignation
2nd Feb 202410:02 amRNSDirector Resignation
19th Dec 20231:10 pmRNSDirector's Dealings and TR-1 Notification
30th Nov 20237:00 amRNSInterim Results
2nd Nov 20237:00 amRNSLaunch of Streaks Companion
21st Sep 20237:00 amRNSLaunch of Streaks Idols Social Product
29th Aug 20237:00 amRNSChange of Board Composition
16th Aug 202312:45 pmRNSResults of Annual General Meeting
3rd Aug 20237:00 amRNSPartnership with WeShop
17th Jul 20237:00 amRNSNotice of AGM
10th Jul 20237:00 amRNSChange of Name
30th Jun 20237:03 amRNSAnnual Results
30th Jun 20237:00 amRNSStreaks Social AI Product Launch / Warrants Issue
24th Mar 20237:00 amRNSAdvertising Partnership with William Hill US
20th Feb 20237:00 amRNSBoard Appointments
2nd Feb 20237:00 amRNSFanDuel Partnership
18th Jan 20237:00 amRNSYear-over-Year Performance
5th Jan 20237:00 amRNSAdmission to the Official List
8th Aug 200810:08 amRNSStatement re Forecast of Year
10th Jun 200812:16 pmRNSStatement re Dividends Receip
6th Jun 200811:06 amRNSStatement re Partial Correcti
30th May 200810:17 amRNSStatement re Concerning Disso
23rd May 200812:47 pmRNSStatement re Announcement of
23rd May 200810:50 amRNSRe Partial Changes in Article
23rd May 200810:32 amRNSStatement re Concerning Parti
23rd May 200810:29 amRNSStatement re Correction of Fi
23rd May 200810:15 amRNSStatement re Conceming Correc
25th Apr 200812:46 pmRNSAcquisition of Shares
25th Apr 200812:42 pmRNSValuation.@Loss
27th Mar 20089:28 amRNSStatement re Transfer
31st Jan 200812:01 pmRNSStatement re Special Loss
28th Nov 200710:31 amRNSStatement re Earnings
29th Jun 200710:08 amRNSStatement re Securitization
22nd Jun 200711:43 amRNSStatement re (Dividend)
21st Jun 20071:14 pmRNSPartial Correction
19th Jun 20073:33 pmRNSStatement re Affiliated Co
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.